Research overview based on the cited scientific literature.

• Goal: Support tissue repair, wound healing, and musculoskeletal recovery in research contexts[1][3].

• Storage: Lyophilized frozen; reconstituted refrigerated; use within 14 days[6].

Proper storage preserves peptide quality and stability.
• Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure[6].
• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 14 days and avoid freeze-thaw cycles[7].
• Allow vials to reach room temperature before opening to reduce condensation uptake.

BPC-157 is a synthetic pentadecapeptide (15 amino acids) originally isolated from human gastric juice. Preclinical research indicates it exerts cytoprotective effects across multiple organ systems, promotes angiogenesis, modulates nitric oxide pathways, and interacts with growth-factor systems involved in tissue repair[1][2]. TB-500 (Thymosin β4) is a naturally occurring peptide that regulates actin polymerization, promotes cell migration, reduces inflammation, and supports wound healing and tissue regeneration[3][4]. The combination is hypothesized to provide complementary mechanisms for accelerated musculoskeletal and soft-tissue recovery.

Observations from preclinical and early clinical literature.
• Tissue Repair: Both peptides demonstrate wound-healing, tendon-repair, and anti-inflammatory properties in animal models[1][3][10].
• Gastrointestinal Support: BPC-157 shows gastroprotective and ulcer-healing effects in preclinical studies[2].
• Safety Profile: Preclinical data indicate a wide safety margin for BPC-157 (no lethal dose up to ~20 mg/kg); TB-500 human tolerability studies report mild adverse events at doses up to 1,260 mg[5][11].
• Possible Side Effects: Occasional mild injection-site reactions (redness, itching); rare reports of transient dizziness or nausea; long-term human safety data remain limited.